Literature DB >> 2302262

A toxicity index for comparison of side effects among different drugs.

J F Fries1, P W Spitz, C A Williams, D A Bloch, G Singh, H B Hubert.   

Abstract

Entities:  

Mesh:

Year:  1990        PMID: 2302262     DOI: 10.1002/art.1780330117

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  15 in total

Review 1.  Safety, cost and effectiveness issues with disease modifying anti-rheumatic drugs in rheumatoid arthritis.

Authors:  J F Fries
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  Toxicity of antirheumatic and anti-inflammatory drugs in children.

Authors:  B Flatø; O Vinje; O Førre
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

Review 3.  Economic and quality-of-life impact of NSAIDs in rheumatoid arthritis: A conceptual framework and selected literature review.

Authors:  S E Gabriel; E L Matteson
Journal:  Pharmacoeconomics       Date:  1995-12       Impact factor: 4.981

4.  Analysis of the costs of NSAID-associated gastropathy. Experience in a US health maintenance organisation.

Authors:  R E Johnson; M C Hornbrook; R S Hooker; G T Woodson; R Shneidman
Journal:  Pharmacoeconomics       Date:  1997-07       Impact factor: 4.981

Review 5.  Management of adverse effects of disease-modifying antirheumatic drugs.

Authors:  M J Wijnands; P L van Riel
Journal:  Drug Saf       Date:  1995-10       Impact factor: 5.606

6.  Purine enzymes in patients with rheumatoid arthritis treated with methotrexate.

Authors:  A E van Ede; R F J M Laan; R A De Abreu; A B J Stegeman; L B A van de Putte
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

Review 7.  Measuring the effects of medication use on health-related quality of life in patients with rheumatoid arthritis. A review.

Authors:  M B Nichol; A S Harada
Journal:  Pharmacoeconomics       Date:  1999-11       Impact factor: 4.981

Review 8.  Management of childhood arthritis. Part 2: Chronic arthritis.

Authors:  P N Malleson
Journal:  Arch Dis Child       Date:  1997-06       Impact factor: 3.791

9.  Leptin consumption in the inflamed joints of patients with rheumatoid arthritis.

Authors:  M Bokarewa; D Bokarew; O Hultgren; A Tarkowski
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

Review 10.  A risk-benefit assessment of slow-acting antirheumatic drugs in rheumatoid arthritis.

Authors:  A A Kalla; A F Tooke; E Bhettay; O L Meyers
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.